We saw significant increases in liver HO-1 expression in both the human and murine liver samples compared to fatty liver patients without MASH and healthy mice, respectively (Fig. 1A and B). This evidence concerns the gene HMOX1 and metabolic dysfunction-associated steatohepatitis.